Ancera LLC, a Branford, Conn.-based developer of a portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids, raised an undisclosed amount of funding.
Backers included Connecticut Innovations, which committed $150k, LaunchCapital and other unnamed angel investors.
Ancera’s platform is based on technology it is licensing exclusively from Yale University. The technology uses magnetic fields to manipulate biologic cells via a ferromagnetic fluid.
Ancera said its technology platform will be useful in food safety testing (e.g., testing for the presence of E.coli bacteria), point-of-care diagnostics and in vitro diagnostics.
The platform will be sold initially to research labs as well as CLIA labs working in pathogen detection.
FinSMEs
14/03/2013